The genetic testing
industry, all in one place.

Roche Korea receives KSMO recognition for contributions to cancer precision medicine, highlighting genomics-driven oncology's growing footprint in Asia.

FDA clearance of Guardant's first genomic-epigenomic liquid biopsy panel sent shares surging 25%, marking a milestone for oncology diagnostics.

Singapore's NPM program publishes findings on translating large-scale genomic data into real-world healthcare practice, advancing precision medicine.

Former BioNTech scientists raise $25M to develop a virtual cancer surveillance startup targeting early detection and monitoring.

Stanford Medicine researchers are reconsidering foundational approaches to genome sequencing to make precision medicine more clinically actionable.

Mount Sinai's new center combines genomic AI and microbiome medicine to push precision diagnostics and treatment into clinical practice.

The whole exome sequencing market is on track to reach $10.24 billion, driven by surging clinical adoption and precision medicine integration.

Gene Solutions, Vietnam's leading genomics company, is pursuing a Hong Kong IPO to finance its expansion across Southeast Asia.